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background:  Troponin elevation has established diagnostic and prognostic value in patients with chest pain (+CP) and suspected acute 
coronary syndrome. Limited data exist regarding its value without CP (-CP). This study evaluated characteristics and outcome of -CP 
patients presenting to the emergency department (ED) with troponin measurement.
methods:  Retrospective study including all patients presenting to an urban Emergency department (Abbott Northwestern Hospital , 
Minneapolis, MN) during 2013 with troponin I (TnI-Abbott Architect Assay) measurement (detection limit 0.01 ng/ml; 99th percentile > 0.034 
ng/ml). Patients were divided into +CP and -CP; chart reviews were conducted on a -CP subset.
Results:  Of 47,053 ED patients, TnI was measured in 9,110 (19%): 6451 (71%) -CP and 2659 (29%) +CP. -CP patients were older 72 
+ 16 vs 64 + 17 years; p < 0.001 and more often female 51% vs 46%; p 0.003. In +CP patients, peak TnI was < 99% in 2,051(82%) and 
> 99% in 488 (18%) vs 4,921 (76%) < 99% and 1,530 (26%) ≥ 99% for -CP; p = 0.1. Among patients with TnI > 99%, PCI/CABG was 
performed in 2% of -CP vs 18% of +CP patients; p < 0.001. Of the -CP patients with detectable troponin, detailed chart reviews in 533 pts 
revealed cardiology consult in 45%, echocardiography in 57%, coronary angiography in 10%, and PCI/CABG in 2%. Comparison of -CP 
patients with TnI < 99% vs > 99% revealed median length of stay 73 vs 101 hrs; p<0.001, PCI/CABG 1% vs 2%; p=1.00, readmission at 30 
days 55% vs 59%; p=0.50, hospital variable costs $3620 vs $5524; p<0.001, and 30 day mortality 5% vs 7%; p<0.36. Leading discharge 
diagnoses were congestive heart failure (CHF) (48%), respiratory failure (24%), and pneumonia (12%). Discharge diagnosis of acute 
myocardial infarction was present in 13 (2%). Leading causes of death were respiratory failure (24%) and CHF (21%).
conclusion:  Among U.S. patients presenting to an urban ED, troponin measurement is performed primarily (> 70%) in -CP. These patients 
have very low frequency of PCI/CABG, yet substantial risk for 30-day readmission and death, largely due to conditions other than acute 
coronary syndrome. These issues will be of increasing importance with the introduction of high sensitivity troponin assays in the US.
